Q0521 HCPCS Level II code: Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
Q0521 is the HCPCS code for “Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
Q0521Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
Short description: Supply fee hiv prep fda appr
HCPCS · United States
Medicare details
The indicators CMS publishes with Q0521 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- DMEPOS fee schedule – Carrier priced (e.g., not otherwise classified, individual determination, carrier discretion, gap-filled amounts)
- Type of service
- Other medical items or services
- BETOS category
- Other drugs
- Coverage statute
- 1861(ddd)
- Added
- Jan 1, 2025
Where Q0521 sits
- 1Q codesTemporary codes
- 2Active code Q0521Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code Q0521 mean?
Q0521 is the HCPCS code for “Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover Q0521?
CMS lists Q0521’s Medicare coverage as “Special coverage instructions apply” and its pricing as “DMEPOS fee schedule – Carrier priced (e.g., not otherwise classified, individual determination, carrier discretion, gap-filled amounts)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q0521
All Q codesQ0515Injection, sermorelin acetate, 1 microgramQ0516Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-daysQ0517Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-daysQ0518Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-daysQ0519Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-daysQ0520Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-daysQ1004New technology intraocular lens category 4 as defined in federal register noticeQ1005New technology intraocular lens category 5 as defined in federal register noticeQ2004Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 mlQ2009Injection, fosphenytoin, 50 mg phenytoin equivalentQ2017Injection, teniposide, 50 mgQ2026Injection, radiesse, 0.1 ml